Irbesartan 300 mg tablets recalled for impurity in active ingredient
Lupin Pharmaceuticals is recalling Irbesartan 300 mg tablets due to the detection of N-nitrosoirbesartan impurity in the active pharmaceutical ingredient. The recall affects approximately 119,544 bottles distributed nationally.
- Product
- IRBESARTAN — IRBESARTAN (IRBESARTAN)
- Category
- Drug
- Distribution
- Distributed nationwide